USPTO serial 79111855
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Cambridgeshire PE29 6UA, GB
Cambridgeshire PE29 6UA, GB
Cambridgeshire PE29 6UA, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark B. Harrison
MARK HARRISON VENABLEP.O. BOX 34385WASHINGTON, DC 20043-9998UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; chemicals for use in the manufacture of medical and veterinary products; chemicals being artificial plant extracts for use in industry and science | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations for treating neurodegenerative diseases, ophthalmological disorders and diseases, central nervous system disorders and diseases, and inflammatory disease; pharmaceutical preparations for the treatment of infectious diseases, and diseases and disorders in the field of, oncology, hepatology, nephrology, cardiovascular, vascular, respiratory, serology, immunology, hematology, metabolism, neurology and neurodegeneration, neuropathies, pain, gastrointestinal, dermatology, muscoskeletal, central nervous system, endocrinology, hormonal, psychiatric, dementia, urology, obstetrics and gynaecology, ophthalmology, inflammation, odontology, dentistry, cognition, genetic disorders, cerebrovascular, eating disorders, hearing, hypothalamic and pituitary diseases, and sleep disorders | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, medical research, chemistry research, biochemistry research, pharmaceutical research; research and development of pharmaceuticals and veterinary preparations and products; biological, biochemical and chemistry research services; drug discovery services; medical and scientific research, namely, conducting clinical trials for others; preclinical services, namely, scientific research services in the nature of characterization, optimization, profiling of efficacy, toxicity and therapeutic effect of drugs and scientific research analysis, testing and monitoring of biological and chemical material in the area of identification and characterization of medical and veterinary conditions, illnesses and diseases; scientific research and consultancy services in the fields of preclinical and clinical trials for pharmaceuticals and veterinary preparations and products; medical and veterinary research services | SECTION 71 - CANCELLED | — |
| 044 | Medical services; veterinary services; medical analysis for the diagnosis and treatment of persons; veterinary analysis for the diagnosis and treatment of animals and birds; medical and veterinary consulting services in the field of pharmaceutical and veterinary products; medical and veterinary consulting services in the field of plant extracts for pharmaceutical and veterinary use; clinical diagnostic services, namely, investigation in the nature of diagnosis, analysis, testing and monitoring of patients for the purpose of identification and characterization of patients before, during and after therapy or treatment | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 8, 2022 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 8, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jan 22, 2022 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Dec 20, 2021 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Dec 20, 2021 | INPC | INVALIDATION PROCESSED | — |
| Oct 26, 2021 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 26, 2021 | C71T | CANCELLED SECTION 71 | — |
| Mar 6, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 19, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 19, 2014 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 19, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 19, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 3, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 28, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 28, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 14, 2013 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 30, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 25, 2013 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 25, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2013 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 25, 2013 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 27, 2012 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 27, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 30, 2012 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Nov 30, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 20, 2012 | ALIE | ASSIGNED TO LIE | — |
| Nov 14, 2012 | PAPER RECEIVED | — | |
| Jun 7, 2012 | RFNP | REFUSAL PROCESSED BY IB | — |
| May 15, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 15, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 12, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 11, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 4, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 3, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |